Yves Cambet

476 total citations
17 papers, 368 citations indexed

About

Yves Cambet is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Yves Cambet has authored 17 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Yves Cambet's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), Synthesis and biological activity (2 papers) and Quinazolinone synthesis and applications (2 papers). Yves Cambet is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), Synthesis and biological activity (2 papers) and Quinazolinone synthesis and applications (2 papers). Yves Cambet collaborates with scholars based in Switzerland, United States and Denmark. Yves Cambet's co-authors include John F. DeLamarter, James Whelan, Rob Hooft van Huijsduijnen, Paola Ghersa, Vincent Jaquet, Dennis Church, Steve Arkinstall, Anthony C. Nichols, Christian Chabert and Jean‐Pierre Gotteland and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and European Journal of Cancer.

In The Last Decade

Yves Cambet

17 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yves Cambet Switzerland 9 184 89 62 49 34 17 368
Jin Namkoong United States 12 400 2.2× 30 0.3× 44 0.7× 97 2.0× 27 0.8× 21 613
Xuan Qin China 12 117 0.6× 42 0.5× 56 0.9× 65 1.3× 5 0.1× 24 315
Huang‐Ju Tu Taiwan 14 252 1.4× 31 0.3× 35 0.6× 120 2.4× 26 0.8× 25 403
Mariya Misheva United Kingdom 5 272 1.5× 18 0.2× 70 1.1× 58 1.2× 15 0.4× 7 465
Yuki Nagano Japan 8 272 1.5× 61 0.7× 29 0.5× 64 1.3× 13 0.4× 12 419
Latika Singh United States 15 315 1.7× 118 1.3× 106 1.7× 114 2.3× 7 0.2× 31 616
Ehsan Amin Germany 13 401 2.2× 24 0.3× 29 0.5× 83 1.7× 11 0.3× 22 609
Philip A. Shelton United Kingdom 11 404 2.2× 65 0.7× 73 1.2× 53 1.1× 10 0.3× 13 606
Changyu Ren China 11 261 1.4× 38 0.4× 37 0.6× 64 1.3× 21 0.6× 19 417
Jaya Gautam South Korea 13 247 1.3× 59 0.7× 85 1.4× 93 1.9× 5 0.1× 19 472

Countries citing papers authored by Yves Cambet

Since Specialization
Citations

This map shows the geographic impact of Yves Cambet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Cambet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Cambet more than expected).

Fields of papers citing papers by Yves Cambet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Cambet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Cambet. The network helps show where Yves Cambet may publish in the future.

Co-authorship network of co-authors of Yves Cambet

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Cambet. A scholar is included among the top collaborators of Yves Cambet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Cambet. Yves Cambet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Makridakis, Manousos, et al.. (2025). Redox Mechanisms Driving Skin Fibroblast-to-Myofibroblast Differentiation. Antioxidants. 14(4). 486–486. 1 indexed citations
2.
Cambet, Yves, et al.. (2023). Genetic knockout of NTRK2 by CRISPR/Cas9 decreases neurogenesis and favors glial progenitors during differentiation of neural progenitor stem cells. Frontiers in Cellular Neuroscience. 17. 1289966–1289966. 3 indexed citations
3.
Galdadas, Ioannis, Martin Smieško, Yves Cambet, et al.. (2023). The action of physiological and synthetic steroids on the calcium channel CatSper in human sperm. Frontiers in Cell and Developmental Biology. 11. 1221578–1221578. 7 indexed citations
4.
Chemaly, Antoun El, Vincent Jaquet, Yves Cambet, et al.. (2023). Discovery and validation of new Hv1 proton channel inhibitors with onco-therapeutic potential. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(3). 119415–119415. 8 indexed citations
5.
Seredenina, Tamara, Anna Faivre, Yves Cambet, et al.. (2023). NADPH oxidase 4 is dispensable for skin myofibroblast differentiation and wound healing. Redox Biology. 60. 102609–102609. 22 indexed citations
6.
Zang, Jie, Yves Cambet, Vincent Jaquet, & Anders Bach. (2023). Chemical synthesis of a reported p47phox/p22phox inhibitor and characterization of its instability and irreproducible activity. Frontiers in Pharmacology. 13. 1075328–1075328. 6 indexed citations
7.
Zang, Jie, Yves Cambet, Eugenia Cifuentes-Pagano, et al.. (2023). Targeting NOX2 with Bivalent Small-Molecule p47phox–p22phox Inhibitors. Journal of Medicinal Chemistry. 66(21). 14963–15005. 8 indexed citations
8.
Jaquet, Vincent, Sylvain Lemeille, Eve-Julie Bonetti, et al.. (2022). Transcriptomic Analysis of E. coli after Exposure to a Sublethal Concentration of Hydrogen Peroxide Revealed a Coordinated Up-Regulation of the Cysteine Biosynthesis Pathway. Antioxidants. 11(4). 655–655. 18 indexed citations
9.
Tseligka, Eirini D., et al.. (2022). Identification of selective hepatitis delta virus ribozyme inhibitors by high-throughput screening of small molecule libraries. JHEP Reports. 5(3). 100652–100652. 2 indexed citations
10.
Preynat‐Seauve, Olivier, Sébastien Tardy, Yves Cambet, et al.. (2021). Novel Mechanism for an Old Drug: Phenazopyridine is a Kinase Inhibitor Affecting Autophagy and Cellular Differentiation. Frontiers in Pharmacology. 12. 664608–664608. 9 indexed citations
11.
Rousset, Francis, Sten Ilmjärv, Antoine Marteyn, et al.. (2020). Redox activation of excitatory pathways in auditory neurons as mechanism of age-related hearing loss. Redox Biology. 30. 101434–101434. 39 indexed citations
12.
Augsburger, Fiona, et al.. (2019). NOX5 Cell-Free Assay for the High-Throughput Screening of Small Molecules. Methods in molecular biology. 1982. 103–111. 2 indexed citations
13.
Chêne, Laurent, Sandrine Jacquet, Yves Cambet, et al.. (2014). 557 A rational approach for discovery of inhibitors of YAP-TEAD interaction. European Journal of Cancer. 50. 180–180. 2 indexed citations
14.
Perrin, Dominique, et al.. (2006). Overcoming the Hurdle of Fluorescent Compounds in Kinase Screening: A Case Study. Assay and Drug Development Technologies. 4(2). 185–196. 9 indexed citations
15.
Gaillard, P., Steve Arkinstall, Yves Cambet, et al.. (2005). Design and Synthesis of the First Generation of Novel Potent, Selective, and in Vivo Active (Benzothiazol-2-yl)acetonitrile Inhibitors of the c-Jun N-Terminal Kinase. Journal of Medicinal Chemistry. 48(14). 4596–4607. 105 indexed citations
16.
Rückle, Thomas, Marco A. Biamonte, Steve Arkinstall, et al.. (2004). Design, Synthesis, and Biological Activity of Novel, Potent, and Selective (Benzoylaminomethyl)thiophene Sulfonamide Inhibitors of c-Jun-N-Terminal Kinase. Journal of Medicinal Chemistry. 47(27). 6921–6934. 53 indexed citations
17.
Ghersa, Paola, et al.. (1994). Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway.. Journal of Biological Chemistry. 269(46). 29129–29137. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin Namkoong Breakdown of academic impact, for papers by Xuan Qin Breakdown of academic impact, for papers by Huang‐Ju Tu Breakdown of academic impact, for papers by Mariya Misheva Breakdown of academic impact, for papers by Yuki Nagano Breakdown of academic impact, for papers by Latika Singh Breakdown of academic impact, for papers by Ehsan Amin Breakdown of academic impact, for papers by Philip A. Shelton Breakdown of academic impact, for papers by Changyu Ren Breakdown of academic impact, for papers by Jaya Gautam
Rankless by CCL
2026